CD39 Expression in Peripheral CD4+ T Lymphocytes Is Associated With Disease Activity in Patients With Systemic Lupus...

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• Regulatory T cells (Tregs) and CD4-positive T cells are vital for controlling Systemic Lupus Erythematosus (SLE).
• CD39, a key enzyme in adenosine metabolism, impacts lymphocyte subsets, including CD4+ T cells and Tregs.

Purpose of the Study:

• To investigate the relationship between SLE disease activity and the counts of Tregs and CD4-positive T lymphocytes.
• To analyze the expression levels of CD39 on these immune cells in SLE patients.
• To evaluate CD39 as a potential biomarker for SLE disease activity.

Main Methods:

• Peripheral blood samples from 108 SLE patients were analyzed using flow cytometry.
• Patients were categorized into active and low-activity SLE groups.
• Quantified proportions and absolute numbers of CD4+ T cells and Tregs, along with CD39 expression, and correlated these with disease activity.

Main Results:

• Active SLE patients showed higher CD4+ T cell counts but lower Treg numbers compared to the low-activity group.
• Increased CD39 expression was observed on both Tregs and CD4+ T cells in active SLE patients.
• CD39 expression on Tregs positively correlated with Treg numbers, while on CD4+ T cells, it negatively correlated.

Conclusions:

• CD39 on CD4-positive T cells appears to mediate immunosuppression, similar to Tregs.
• The CD4+CD39+ T lymphocyte subset may represent a more precise marker for distinguishing SLE disease activity.